Listar por tema "Factor Xa Inhibitors"

Mostrando ítems 1-2 de 2

Branch atheromatous disease diagnosed as embolic stroke of undetermined source: A sub-analysis of NAVIGATE ESUS

Uchiyama, Shinichiro; Toyoda, Kazunori; Kitagawa, Kazuo; Okada, Yasushi; Ameriso, Sebastián Francisco; Mundl, Hardi; Berkowitz, Scott D.; Yamada, Takashi; Liu, Yan Yun; Hart, Robert G.; NAVIGATE ESUS Investigators (Sage, 2019-05-17)

Background: Branch atheromatous disease (BAD) is distinctive from large and small arterial diseases, which is single subcortical infarction larger than lacunar stroke in the territories of deep perforators without relevant ...
Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban Versus Aspirin According to Risk Status: The NAVIGATE ESUS Trial

Hart, Robert G.; Veltkamp, Roland C.; Sheridan, Patrick; Sharma, Mukul; Kasner, Scott E.; Bangdiwala, Shrikant I.; Ntaios, George; Shoamanesh, Ashkan; Ameriso, Sebastián Francisco; Toni, Danilo; Czlonkowska, Anna; Lindgren, Arne; Hankey, Graeme J.; Perera, Kanjana S.; Shuaib, Ashfaq; Coutts, Shelagh B.; Gagliardi, Rubens J.; Berkowitz, Scott D.; Mundl, Hardi; NAVIGATE ESUS Investigators (Elsevier, 2019-05-31)

Background: Embolic stroke of undetermined source (ESUS) identifies patients with cryptogenic ischemic stroke presumed due to embolism from several unidentified sources. Among patients with recent ESUS, we sought to determine ...

Buscar en DSpace